-transparent.png){kind=logo}
The authors treated 12 consecutive bulimic patients with nomifensine, a novel antidepressant recently approved for American use. Two patients developed fever, necessitating discontinuation of the drug. Of the other 10 patients, nine showed moderate or better improvement, with strikingly few side effects.
Related Publications
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
March 1986,
The American journal of psychiatry,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
October 1979,
Activitas nervosa superior,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
July 1983,
Arthritis and rheumatism,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
May 1981,
Ugeskrift for laeger,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
October 1984,
The American journal of psychiatry,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
January 1982,
Psychopharmacology,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
December 1985,
Drug and therapeutics bulletin,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
October 1997,
Archives of general psychiatry,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
October 2001,
The Annals of pharmacotherapy,
H G Pope, and
P L Herridge, and
J I Hudson, and
R Fontaine, and
D Yurgelun-Todd
November 1983,
Drug intelligence & clinical pharmacy,
